| Towards a universal influenza vaccine: different approaches for one goal GA Sautto, GA Kirchenbaum, TM Ross Virology journal 15, 1-12, 2018 | 221 | 2018 |
| Extremely potent human monoclonal antibodies from COVID-19 convalescent patients E Andreano, E Nicastri, I Paciello, P Pileri, N Manganaro, G Piccini, ... Cell 184 (7), 1821-1835. e16, 2021 | 191 | 2021 |
| Alternative methods of vaccine delivery: an overview of edible and intradermal vaccines E Criscuolo, V Caputo, RA Diotti, GA Sautto, GA Kirchenbaum, ... Journal of immunology research 2019, 2019 | 114 | 2019 |
| Chimeric antigen receptor (CAR)-engineered T cells redirected against hepatitis C virus (HCV) E2 glycoprotein GA Sautto, K Wisskirchen, N Clementi, M Castelli, RA Diotti, J Graf, ... Gut 65 (3), 512-523, 2016 | 90 | 2016 |
| Hepatitis C virus (HCV) infection may elicit neutralizing antibodies targeting epitopes conserved in all viral genotypes N Mancini, RA Diotti, M Perotti, G Sautto, N Clementi, G Nitti, AH Patel, ... PloS one 4 (12), e8254, 2009 | 77 | 2009 |
| Monoclonal antibodies isolated from human B cells neutralize a broad range of H1 subtype influenza A viruses including swine-origin Influenza virus (S-OIV) R Burioni, F Canducci, N Mancini, N Clementi, M Sassi, D De Marco, ... Virology 399 (1), 144-152, 2010 | 63 | 2010 |
| Structural and antigenic definition of hepatitis C virus E2 glycoprotein epitopes targeted by monoclonal antibodies G Sautto, AW Tarr, N Mancini, M Clementi Journal of Immunology Research 2013, 2013 | 62 | 2013 |
| A computationally optimized broadly reactive antigen subtype–specific influenza vaccine strategy elicits unique potent broadly neutralizing antibodies against hemagglutinin GA Sautto, GA Kirchenbaum, RB Abreu, JW Ecker, SR Pierce, ... The Journal of Immunology 204 (2), 375-385, 2020 | 54 | 2020 |
| Preexisting subtype immunodominance shapes memory B cell recall response to influenza vaccination RB Abreu, GA Kirchenbaum, EF Clutter, GA Sautto, TM Ross JCI insight 5 (1), 2020 | 45 | 2020 |
| Peptide-based vaccinology: experimental and computational approaches to target hypervariable viruses through the fine characterization of protective epitopes recognized by … M Castelli, F Cappelletti, RA Diotti, G Sautto, E Criscuolo, M Dal Peraro, ... Journal of Immunology Research 2013, 2013 | 40 | 2013 |
| The answer lies in the energy: how simple atomistic molecular dynamics simulations may hold the key to epitope prediction on the fully glycosylated SARS-CoV-2 spike protein SA Serapian, F Marchetti, A Triveri, G Morra, M Meli, E Moroni, GA Sautto, ... The Journal of Physical Chemistry Letters 11 (19), 8084-8093, 2020 | 39 | 2020 |
| High-yield expression and purification of recombinant influenza virus proteins from stably-transfected mammalian cell lines JW Ecker, GA Kirchenbaum, SR Pierce, AL Skarlupka, RB Abreu, ... Vaccines 8 (3), 462, 2020 | 39 | 2020 |
| IgA responses following recurrent influenza virus vaccination RB Abreu, EF Clutter, S Attari, GA Sautto, TM Ross Frontiers in immunology 11, 528797, 2020 | 39 | 2020 |
| A biologically-validated HCV E1E2 heterodimer structural model M Castelli, N Clementi, J Pfaff, GA Sautto, RA Diotti, R Burioni, BJ Doranz, ... Scientific reports 7 (1), 214, 2017 | 38 | 2017 |
| Molecular cloning of the first human monoclonal antibodies neutralizing with high potency swine-origin influenza A pandemic virus (S-OIV). R Burioni, F Canducci, N Mancini, N Clementi, M Sassi, D De Marco, ... The new microbiologica 32 (4), 319, 2009 | 37 | 2009 |
| Elicitation of broadly protective antibodies following infection with influenza viruses expressing H1N1 computationally optimized broadly reactive hemagglutinin antigens GA Sautto, GA Kirchenbaum, JW Ecker, AG Bebin-Blackwell, SR Pierce, ... Immunohorizons 2 (7), 226-237, 2018 | 36 | 2018 |
| Anti-hepatitis C virus E2 (HCV/E2) glycoprotein monoclonal antibodies and neutralization interference G Sautto, N Mancini, RA Diotti, L Solforosi, M Clementi, R Burioni Antiviral research 96 (1), 82-89, 2012 | 36 | 2012 |
| A phage display vector optimized for the generation of human antibody combinatorial libraries and the molecular cloning of monoclonal antibody fragments L Solforosi, N Mancini, F Canducci, N Clementi, GA Sautto, RA Diotti, ... New Microbiologica 35 (3), 289-294, 2012 | 34 | 2012 |
| Neutralization interfering antibodies: a “novel” example of humoral immune dysfunction facilitating viral escape? M Nicasio, G Sautto, N Clementi, RA Diotti, E Criscuolo, M Castelli, ... Viruses 4 (9), 1731-1752, 2012 | 30 | 2012 |
| HCV E2 core structures and mAbs: something is still missing M Castelli, N Clementi, GA Sautto, J Pfaff, KM Kahle, T Barnes, BJ Doranz, ... Drug discovery today 19 (12), 1964-1970, 2014 | 29 | 2014 |
Massimo ClementiProfessore di Microbiologia e Virologia, Università Vita-Salute San Raffaele, Milano, ItalyEmail verificata su hsr.it
